Organization and Nature of the Business - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands					1 Months Ended		3 Months Ended
	Jan. 23, 2024	Jan. 22, 2024	Aug. 31, 2022	Mar. 12, 2021	Jan. 31, 2024	Nov. 30, 2022	Mar. 31, 2025	Mar. 31, 2024	Apr. 07, 2025	Dec. 31, 2024
Schedule Of Equity Method Investments [Line Items]
Outstanding warrants, Weighted average exercise price		$ 2.3999
Common stock price per share		$ 0.0001					$ 0.0001			$ 0.0001
Issuance of common stock		5,325,000					82,709,625			82,569,168
Estimated offering expenses	$ 91,700
Aggregate gross proceeds							$ 0	$ 19,266
Accumulated deficit							(526,108)			$ (497,894)
Underwriting discounts and commissions and other offering expenses		$ 91,700
Adicet Therapeutics [Member]
Schedule Of Equity Method Investments [Line Items]
Accumulated deficit							$ 526,100
2021 Sales Agreement
Schedule Of Equity Method Investments [Line Items]
Aggregate number of shares sold			2,611,723
Sale of Stock, Price Per Share			$ 17.23
Sales agent commissions and expenses			$ 43,400
Aggregate net proceed					$ 19,300
Common Stock not sold						$ 30,000
Additional Common Stock not sold						70,000
Aggregate gross proceeds						$ 100,000
Common Stock
Schedule Of Equity Method Investments [Line Items]
Common stock price per share									$ 1
Issuance of common stock		5,325,000
Common Stock | Jefferies LLC
Schedule Of Equity Method Investments [Line Items]
Outstanding warrants, Weighted average exercise price		$ 2.4
Warrants outstanding		8,445,333
Common stock price per share		$ 0.0001
Issuance of common stock		27,054,667
Pre Funded Warrant | Jefferies LLC
Schedule Of Equity Method Investments [Line Items]
Underwriting agreement to purchase					30
Discount on underwriters warrant		6.00%
Purchase price per share		$ 2.2559
Outstanding warrants, Weighted average exercise price		2.3999
Pre Funded Warrant | Jefferies LLC | Initial Public Offering
Schedule Of Equity Method Investments [Line Items]
Outstanding warrants, Weighted average exercise price		$ 0.0001
Maximum | 2021 Sales Agreement
Schedule Of Equity Method Investments [Line Items]
Aggregate gross proceeds				$ 75,000
Maximum | Common Stock
Schedule Of Equity Method Investments [Line Items]
Common stock price per share									1
Minimum | Common Stock
Schedule Of Equity Method Investments [Line Items]
Common stock price per share									$ 0.0001